Since the establishment of the first medicinal cannabis schemes in California and Israel in the 1990s, a growing number of countries have legalised access to cannabis-based products for medicinal use. Aotearoa New Zealand is one of the latest countries. Read more
Lived experience of affordability as a barrier to prescription medicines: A longitudinal qualitative study
Lived experience of affordability as a barrier to prescription medicines: A longitudinal qualitative study
Exploring lived experience provides insights into the multiple ways that lack of affordability prevents access to medicines: directly, through interaction with other barriers to access including transport, by damaging trust and reducing acceptability of services, and by making participants less able to deal with mistakes made by health professionals.